EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ZFHX3 Knockdown Enhances Metabolic Distress in Atrial Myocytes Through Mitochondrial and Calcium Dysregulation: Mitigation by Trimetazidine

Baigalmaa Lkhagva iD, Shuen-Hsin Liu, Satoshi Higa iD, Yu-Hsun Kao, Yi-Jen Chen iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Baigalmaa Lkhagva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Trimetazidine, Myocytes, Cardiac, Calcium, Homeodomain Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taipei Medical University - Shuang Ho Hospital, Foundation for the Development of Internal Medicine in Okinawa, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysregulation in the heart plays a critical role in the pathogenesis of atrial fibrillation (AF), yet the underlying molecular mechanisms remain unclear. Loss-of-function variants in the zinc finger homeobox 3 gene (ZFHX3) increase AF risk by promoting structural and electrical remodeling. However, the role of ZFHX3 knockdown (KD) in cardiac metabolism has not been fully elucidated. This study investigated the impact of ZFHX3 KD on energy metabolism in atrial myocytes and assessed the therapeutic potential of trimetazidine (TMZ). Seahorse XFe24 extracellular flux analysis, bioluminescent assays, microplate enzyme activity assays, and Western blotting were used to study energy substrate (glucose and fatty acid) oxidation stress, intracellular lactate content, glucose uptake, pyruvate dehydrogenase (PDH) activity, and regulatory protein expression in control and ZFHX3 KD HL-1 cells with or without TMZ (10 μM) treatment. ZFHX3 KD cells exhibited a higher acute response in oxygen consumption after Etomoxir injection, upregulated CD36 and phosphorylated ACC expression, increased glucose uptake and lactate production, reduced PDH activity, and higher levels of PDK4 and LDHA. Furthermore, ZFHX3 KD cells showed mitochondrial Ca2+ overload and increased phosphorylated PDH and oxidized CaMKII proteins, all of which were significantly attenuated by TMZ. Additionally, TMZ improved mitochondrial dysfunction in ZFHX3 KD cells by decreasing basal and maximal respiration, spare capacity, and proton leak. These findings suggest that ZFHX3 downregulation shifts substrate preference toward fatty acid utilization at the expense of glucose oxidation, contributing to metabolic and mitochondrial calcium dysregulation. TMZ mitigates these effects, highlighting its therapeutic potential in AF associated with ZFHX3 deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrimetazidineMyocytes, CardiacCalciumHomeodomain ProteinsHeart AtriaMitochondriaMitochondria, HeartAnimalsMiceEnergy MetabolismGene Knockdown TechniquesCell LineGlucoseAtrial Fibrillation

Stichwörter der Autor:innen

atrial fibrillationlactatemitochondrial Ca2+mitochondrial energy metabolismtrimetazidinezinc finger homeobox 3 (ZFHX3)

Substanzen

TrimetazidineCalciumHomeodomain ProteinsGlucose

Autor:innen und Institutionen

  • Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.
  • Cardiac Electrophysiology and Pacing Laboratory, Division of Cardiovascular Medicine, Makiminato Central Hospital, 1199 Makiminato, Urasoe 901-2131, Japan.
  • Department of Medical Education and Research, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.
  • Cardiovascular Research Center, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

ORCID-Profile: Baigalmaa Lkhagva, Satoshi Higa, Yi-Jen Chen

Förderung

  • National Science and Technology Council
  • Taipei Medical University - Shuang Ho Hospital
  • Foundation for the Development of Internal Medicine in Okinawa, Japan
  • National Science and Technology Council, Taiwan
  • Taipei Medical University–Shuang Ho Hospital

Zitieren

APA

Lkhagva, B., Liu, S. H., Higa, S., Kao, Y. H., & Chen, Y. J. (2025). ZFHX3 Knockdown Enhances Metabolic Distress in Atrial Myocytes Through Mitochondrial and Calcium Dysregulation: Mitigation by Trimetazidine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178576

Vancouver

Lkhagva B, Liu SH, Higa S, Kao YH, Chen YJ. ZFHX3 Knockdown Enhances Metabolic Distress in Atrial Myocytes Through Mitochondrial and Calcium Dysregulation: Mitigation by Trimetazidine. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178576

BibTeX
@article{Lkhagva2025,
  author = {Lkhagva, Baigalmaa and Liu, Shuen-Hsin and Higa, Satoshi and Kao, Yu-Hsun and Chen, Yi-Jen},
  title = {ZFHX3 Knockdown Enhances Metabolic Distress in Atrial Myocytes Through Mitochondrial and Calcium Dysregulation: Mitigation by Trimetazidine},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178576}
}
Kostenlos starten →